The company said that if not for those investment losses, the operations would have been profitable.
"You do not win cases nor achieve justice by calling one witness and ordering your staff not to initiate any additional effort to gather evidence," Kline said in a written statement.
The storm intensified when a high-ranking Vatican official supported the excommunications. But then a conference of Brazilian bishops overruled Archbishop Sobrinho, saying that the child’s mother had acted “under pressure” from doctors who said the girl would die if she carried the babies to term, and that only doctors who “systematically” performed abortions should be thrown out of the church.
I pray that God will use this unfortunate catastrophe to soften the hearts of [surviving relatives] and that they will draw close to the Lord....
NEW YORK – The Food and Drug Administration let politics cloud its judgment when it denied teenage girls over-the-counter access to the Plan B morning-after pill, a federal judge said Monday as he ordered the FDA to let 17-year-olds obtain the medication.
In a thorough denunciation of the Bush administration, U.S. District Judge Edward Korman blasted the FDA's handling of the issue, saying it had "repeatedly and unreasonably" delayed issuing a decision on the medication.
The morning-after pill is a source of tension for social conservatives who held great sway in the Bush administration and who believe the pill is tantamount to abortion.
The ruling said the FDA in several instances had delayed issuing a ruling for suspect reasons and on two occasions only took action to facilitate the confirmation of acting FDA commissioners whose confirmations had been held up by the repeated delays.
"These political considerations, delays, and implausible justifications for decision-making are not the only evidence of a lack of good faith and reasoned decision-making," Korman said. "Indeed, the record is clear that the FDA's course of conduct regarding Plan B departed in significant ways from the agency's normal procedures regarding similar applications to switch a drug product from prescription to non-prescription use."
The drug is marketed by Montvale, N.J.-based Barr Pharmaceuticals Inc. as Plan B. Korman ordered the FDA to permit Barr Pharmaceuticals to make Plan B available to 17-year-olds without a prescription under the same conditions as Plan B is now available to women over the age of 18. He said his order must be complied with within 30 days.
The FDA said it is reviewing the judge's decision. Women's groups said it's unlikely that the Obama administration would appeal.
In February 2001, the Association of Reproductive Health Professionals and 65 other organizations petitioned the FDA to make Plan B available over the counter to all, regardless of age. The FDA did not respond for five years, announcing in 2006 that the petition was denied.
As part of his order, Korman vacated the petition's denial and required the FDA to reconsider its decisions regarding the Plan B switch to over-the-counter use.
A federal court today ordered the Food and Drug Administration to reconsider the agency's controversial decision limiting non-prescription access to the morning-after pill Plan B to women age 18 and older.
The conservative Family Research Council said the judge's decision bowed to ideological pressure from the left.
"Judge Korman has accepted lock, stock, and barrel all of the claims of a political ideology promoting sexual license for teens," said Chris Gacek, a regulation expert with the group.
"There is a real danger that Plan B may be given to women, especially sexually abused women and minors, under coercion or without their consent," Gacek added in a statement.
"Particularly disturbing is the crushing yoke of discrimination that women and girls so often endure, not to mention the unspeakable practice of sexual violence and exploitation which causes such humiliation and trauma," Benedict told an audience of government leaders and foreign diplomats in the late afternoon.
He also criticized what he called the "irony of those who promote abortion as a form of 'maternal' health care." The pope was referring to an African Union agreement signed by Angola and 44 other countries that abortion should be legal in cases of rape, incest or when the mother's life is endangered.
"How disconcerting the claim that the termination of life is a matter of reproductive health," Benedict said.
"Parishioners blame women, say we seduce the priests, but we are brought up to respect and honor men, and women can't say no to a priest who is held up to us as a fount of knowledge in daily communication with God," she said.
Co-founder [of Women Ordination South Africa] Dina Cormick said priests who are caught having affairs are sent on retreats or moved to other parishes while nuns caught in sexual liaisons with priests are forced to leave their orders.
Widespread immunization of girls and boys against the human papillomavirus could fully eradicate types 16 and 18 of the virus. If we miss half the equation by leaving the boys out of our vaccination strategy, that type of public health success will not be possible.
The benefits of human papillomavirus (HPV) vaccination in boys are numerous. While protecting women from HPV and the morbidity and mortality associated with cervical cancer is a significant motivation for male vaccination, males would also accrue their own health benefits through vaccination. For example, approximately 12% of oral pharyngeal cancers are caused by HPV types 16 and 18, which also cause some penile and anal cancers. Also, 90% of genital warts are caused by HPV types 6 and 11, which can occur in boys as well as in girls; while not life-threatening, genital warts are certainly anxiety provoking. In addition, one out of four girls and one out of six boys is the victim of sexual abuse by age 20. That's a high number of young people for whom prevention would be relevant.
If we want to achieve herd immunity with HPV, we really need to vaccinate both sexes. There's also a larger message from society in how we choose to formulate our vaccination strategy. If we don't vaccinate boys, we are saying as a society that females alone have the responsibility for society's sexual health.
Men also have a stake in the health of their future sexual partners. While boys may be only 11 or 12 years old when their parents consent to HPV vaccination on their behalf, these boys and their parents will not want their future partners or offspring to be exposed to life-threatening HPV.
The cost-effectiveness estimates for vaccinating boys are not compelling at this point. However, the public health benefit is clear and the medical risks associated with vaccination are extremely low. In fact, the experience with girls in the United States has been excellent, with fewer adverse events reported for the HPV vaccine than for most other common vaccines.
The issue of immunizing males against HPV often comes down to whether they should receive the vaccine to protect females. Doing so is honorable and even reasonable, but at this point there is little evidence suggesting that this is cost effective.
Early cost-benefit analyses of this idea showed that a large number of males would need to be immunized to achieve even a minimal increase in protection for females. At the same time, adding males to the equation would significantly increase the cost of the immunization program. So, until there are more compelling data to show that immunizing males will protect large numbers of females, the right thing to do is to immunize the people we are trying to protect—girls and women themselves.
This said, there are other compelling reasons to consider vaccinating males. Newer data are beginning to show that HPV does more in men than might have been appreciated just a decade ago. A significant portion of head and neck cancers, anal cancers, and cancer of the larynx are caused by HPV. When you start adding up the number of cases of cancers in males attributable to HPV, you end up with roughly the same number as that of cervical cancer cases in the United States. Not to be forgotten is the significant morbidity associated with genital warts. So the reasons to immunize males will likely have more to do with protecting males against the diseases they get, rather than protecting women from cancer.
The catch with male immunization is that the studies showing that HPV vaccines prevent these cancers in men do not yet merit changing our vaccination strategy. When the data are available, I expect we will have sound reasons to immunize males against HPV. But studies showing that these vaccines prevent genital warts have not yet been published, and it will be perhaps 3–5 years before we see strong evidence related to cancer prevention benefits.
RIO DE JANEIRO - A Roman Catholic archbishop says the abortion of twins carried by a 9-year-old girl who allegedly was raped by her stepfather means excommunication for the girl's mother and her doctors.
"The law of God is higher than any human laws," he said. "When a human law — that is, a law enacted by human legislators — is against the law of God, that law has no value. The adults who approved, who carried out this abortion have incurred excommunication."